Nursing notes

Published on March 2017 | Categories: Documents | Downloads: 31 | Comments: 0 | Views: 300
of 16
Download PDF   Embed   Report

Comments

Content

 

Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!



 #ntidote

 Protamine sulfate -mg for each mg of



 

eno!aparin by slo% I in/ection 0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued 

therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug )o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued 

th

therapy. &eparininduced thrombocytopenia occurs on (  day and may lead to

 

increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug )o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 

0arfarin "1oumadin





#ntidote

 itamin 2 "#void "#void foods high in vitamin 2.



Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin

Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs:

 

Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institutehemoglobin, for Safe Medication Practicesand recommends completing a baseline hematocrit, serum creatinine, platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institutehemoglobin, for Safe Medication Practicesand recommends completing a baseline hematocrit, serum creatinine, platelet count coun t before starting patients on

 

anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued 

therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug )o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline

 

information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 

0arfarin "1oumadin





#ntidote

 itamin 2 "#void "#void foods high in vitamin 2.



Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin

Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 

0arfarin "1oumadin





#ntidote

 itamin 2 "#void "#void foods high in vitamin 2.



Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on

 

&eparin

Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin

 

*no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 

Anticoagulation therapy





 No IM drugs during

Anticoagulants are antithrombotic drugs\ complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild 

thrombocytopenia "#ppears on $ th day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug )o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 

Anticoagulation therapy





 No IM drugs during

Anticoagulants are antithrombotic drugs\ complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild 

thrombocytopenia "#ppears on $ th day of therapy and resolves %ith continued

 

therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug )o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

 

 

Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy.

 

The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 

Anticoagulation therapy





 No IM drugs during

 

Anticoagulants are antithrombotic drugs\ complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!



 #ntidote

 Protamine sulfate -mg for each mg of



eno!aparin by slo% I in/ection 0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

 

Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!



 #ntidote

 Protamine sulfate -mg for each mg of



eno!aparin by slo% I in/ection

 

0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to 

increased resist resistance ance to heparin therapy. sulfate sulfthe ate drug is antidote. ue to short half life overdose can be treated b yProtamine by %ithdra%ing )o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to 

increased resist resistance ance to heparin therapy. sulfate sulfthe ate drug is antidote. ue to short half life overdose can be treated b yProtamine by %ithdra%ing

 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild 

 

thrombocytopenia "#ppears on $ th day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug )o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!



 #ntidote

 Protamine sulfate -mg for each mg of



eno!aparin by slo% I in/ection 0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

 

Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug 

)o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!



 #ntidote

 Protamine sulfate -mg for each mg of



eno!aparin by slo% I in/ection 0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Anticoagulation therapy  No IM drugs during Anticoagulants are antithrombotic drugs\ 

complete laboratory tests before the start of anticoagulant therapy to establish baseline information about the patient's coagulation status and to serve as a reference for comparison during therapy. The Institute for Safe Medication Practices recommends completing a baseline hematocrit, hemoglobin, serum creatinine, and platelet count coun t before starting patients on anticoagulant therapy

 

  Types Ty pes of anticoagulant drugs: Unfractionated heparin oes not dissolve e!isting thrombus, but prevents the e!tension of the thrombus and more thrombi from forming. forming. May cause mild th thrombocytopenia "#ppears on $  day of therapy and resolves %ith continued therapy. &eparininduced thrombocytopenia occurs on (th day and may lead to 

increased resistance resistance to heparin therapy. Protamine sulfate sulfate is antidote. ue to short half life overdose can be treated by b y %ithdra%ing the drug )o%molecular%eight heparin "*no!aparin, alteparin, and Tin+aparin *no!aparin ")oveno!  #ntidote  Protamine sulfate -mg for each mg of eno!aparin by slo% I in/ection 



0arfarin "1oumadin #ntidote  itamin 2 "#void "#void foods high in vitamin 2. Ta3es Ta3es 45 days to reach effective levels6 Usually begun b egun %hile patient still on &eparin 



Sponsor Documents

Or use your account on DocShare.tips

Hide

Forgot your password?

Or register your new account on DocShare.tips

Hide

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close